Insiders · Profile

BALDO LANCE

Chief Medical Officer at Adaptive Biotechnologies. Filing since 6 May 2020. CIK 0001780773

Company
Date
Role
Action
Shares
Amount
Of holding
8 Mar 2022
Chief Medical Officer
Sold, plan not stated
3,350
$38.29K
16.3%
7 Mar 2022
Chief Medical Officer
Sold, plan not stated
2,373
$28.50K
10.4%
14 Apr 2021
Chief Medical Officer
Sold, plan not stated
2,000
$89.00K
8.0%
27 Jan 2021
Chief Medical Officer
Sold, plan not stated
40,000
$2.36M
100%
7 Dec 2020
Chief Medical Officer
Sold, plan not stated
6,250
$315.09K
100%
6 Nov 2020
Chief Medical Officer
Sold, plan not stated
6,250
$316.45K
100%
6 Oct 2020
Chief Medical Officer
Sold, plan not stated
6,250
$307.52K
100%
29 Sep 2020
Chief Medical Officer
Sold, plan not stated
25,000
$1.25M
100%
11 Sep 2020
Chief Medical Officer
Sold, plan not stated
4,149
$165.96K
100%
10 Sep 2020
Chief Medical Officer
Sold, plan not stated
18
$720.00
100%
8 Sep 2020
Chief Medical Officer
Sold, plan not stated
2,083
$75.34K
100%
6 Aug 2020
Chief Medical Officer
Sold, plan not stated
6,250
$250.00K
100%
6 Jul 2020
Chief Medical Officer
Sold, plan not stated
6,250
$295.79K
100%
9 Jun 2020
Chief Medical Officer
Sold, plan not stated
4,167
$166.68K
100%
8 Jun 2020
Chief Medical Officer
Sold, plan not stated
2,083
$81.29K
100%
6 May 2020
Chief Medical Officer
Sold, plan not stated
50,000
$1.69M
100%
16 decisions on file.